07:00 , Aug 29, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Cardiovascular disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Hypertension Potassium channel K2p3.1 (KCNK3); phospholipase A2 (PLA2) Studies in patient samples and cell culture suggest activating KCNK3 could help...